| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH |
From the Department of Obstetrics and Gynecology, Helsinki University Central Hospital; National Public Health Institute; and Division of Clinical Chemistry, University of Helsinki, Helsinki, Finland.
Address reprint requests to: Eini Nikander, MD, Department of Obstetrics and Gynecology, Helsinki University Central Hospital, P.O. Box 140, FIN-00029 HUS, Helsinki, Finland; E-mail: eini.nikander{at}pp.fimnet.fi.
OBJECTIVE: Phytoestrogens are popular in treatment of menopause, although scientific evidence is insufficient as to their efficacy. We studied the effects of daily use of isoflavonoids on climacteric symptoms and quality of life in patients with a history of breast cancer.
METHODS: Sixty-two postmenopausal symptomatic women were randomized to use either phytoestrogen (tablets containing 114 mg of isoflavonoids) or a placebo for 3 months; the treatment regimens were reversed after a 2-month washout period. Fifty-six women completed the study. Menopausal symptoms were recorded on the Kupperman index and the visual analogue scale, and working capacity and mood changes were assessed via validated questionnaires. In addition, we followed the levels of phytoestrogens, follicle-stimulating hormone (FSH), luteinizing hormone (LH), estradiol, and sex hormone–binding globulin. Liver enzymes and creatinine were also assessed at each visit.
RESULTS: The phytoestrogen regimen raised the circulating levels of phytoestrogens (daidzein, genistein, equol) 19- to 106-fold. The Kupperman index was reduced by 4.2 ± 9.6 (mean ± standard deviation) (15.5%) during phytoestrogen use and similarly by 4.0 ± 8.1 (14.7%) during placebo use (P nonsignificant). The quality of life parameters (working capacity, mood changes) were unaffected by phytoestrogen. In addition, the phytoestrogen regimen caused no changes in FSH, LH, estradiol, or sex hormone-binding globulin. Phytoestrogen treatment was well tolerated and caused no changes in liver enzymes, creatinine, body mass index, or blood pressure. Of the 56 women, 25 (44.6%) preferred the phytoestrogen regimen, 15 preferred the placebo (26.8%), and 16 (28.6%) reported no preference (nonsignificant).
CONCLUSION: Pure isoflavonoids did not alleviate subjective menopausal symptoms in breast cancer patients.
This article has been cited by other articles:
|
|
 |
|
  C. Duffy, K. Perez, and A. Partridge Implications of Phytoestrogen Intake for Breast Cancer CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nedrow, J. Miller, M. Walker, P. Nygren, L. H. Huffman, and H. D. Nelson Complementary and alternative therapies for the management of menopause-related symptoms: a systematic evidence review. Arch Intern Med, July 24, 2006; 166(14): 1453 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. D. Nelson, K. K. Vesco, E. Haney, R. Fu, A. Nedrow, J. Miller, C. Nicolaidis, M. Walker, and L. Humphrey Nonhormonal therapies for menopausal hot flashes: systematic review and meta-analysis. JAMA, May 3, 2006; 295(17): 2057 - 2071. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Dodin, A. Lemay, H. Jacques, F. Legare, J.-C. Forest, and B. Masse The Effects of Flaxseed Dietary Supplement on Lipid Profile, Bone Mineral Density, and Symptoms in Menopausal Women: A Randomized, Double-Blind, Wheat Germ Placebo-Controlled Clinical Trial J. Clin. Endocrinol. Metab., March 1, 2005; 90(3): 1390 - 1397. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 E. E. Krebs, K. E. Ensrud, R. MacDonald, and T. J. Wilt Phytoestrogens for Treatment of Menopausal Symptoms: A Systematic Review Obstet. Gynecol., October 1, 2004; 104(4): 824 - 836. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Vasomotor Symptoms Obstet. Gynecol., October 1, 2004; 104(4_suppl): 106S - 117S. [Full Text] [PDF]
|
|
|
|
|
|
E. Nikander, A. Tiitinen, K. Laitinen, M. Tikkanen, and O. Ylikorkala Effects of Isolated Isoflavonoids on Lipids, Lipoproteins, Insulin Sensitivity, and Ghrelin in Postmenopausal Women J. Clin. Endocrinol. Metab., July 1, 2004; 89(7): 3567 - 3572. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Harris, D. M. Wood, L. Bottomley, S. Blagg, K. Owen, P. J. Hughes, R. H. Waring, and C. J. Kirk Phytoestrogens Are Potent Inhibitors of Estrogen Sulfation: Implications for Breast Cancer Risk and Treatment J. Clin. Endocrinol. Metab., April 1, 2004; 89(4): 1779 - 1787. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nikander, M. Metsa-Heikkila, O. Ylikorkala, and A. Tiitinen Effects of Phytoestrogens on Bone Turnover in Postmenopausal Women with a History of Breast Cancer J. Clin. Endocrinol. Metab., March 1, 2004; 89(3): 1207 - 1212. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. Nikander, M. Metsa-Heikkila, A. Tiitinen, and O. Ylikorkala Evidence of a Lack of Effect of a Phytoestrogen Regimen on the Levels of C-Reactive Protein, E-Selectin, and Nitrate in Postmenopausal Women J. Clin. Endocrinol. Metab., November 1, 2003; 88(11): 5180 - 5185. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Flash: Plant Estrogens Don't Help Journal Watch Women's Health, August 6, 2003; 2003(806): 1 - 1. [Full Text]
|
|
|
|
 |
|
 Phytoestrogens Do Not Control Menopausal Symptoms Journal Watch (General), June 27, 2003; 2003(627): 9 - 9. [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
